NCT06138977

Controlling Locomotion Over Continuously Varying Activities for Agile Powered Prosthetic Legs

Name: Clinical Trial NCT06138977
Creator: University of Michigan
Keywords: Amputation, Powered prosthesis, device, clinical trial, United States of America

University of Michigan·ClinicalTrials.gov·device·Device trialRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Amputation
Drug/Device/Intervention: Powered prosthesis
Study type: Interventional
Intervention type: device

Sponsor & location

Primary sponsor: University of Michigan
Location: Ann Arbor, United States of America

Timeline & enrollment

Phase: N/A
Start date: Jan 01, 2024
End date: Jan 30, 2028
Enrollment: 40 participants

Primary outcome

Joint work,Tuning time,Endurance test time

Summary

The overall goal of this project is to model human joint biomechanics over continuously-varying locomotion to enable adaptive control of powered above-knee prostheses. The central hypothesis of this project is that variable joint impedance can be parameterized by a continuous model based on measurable quantities called phase and task variables. This project will use machine learning to identify variable impedance functions from able-bodied data including joint perturbation responses across the phase/task space to bias the solution toward biological values.

ICD-10 classifications

Amputation of limb(s)Traumatic amputation of both feetTraumatic amputation of upper and lower limbs, any combination [any level]Traumatic amputations involving other combinations of body regionsTraumatic amputation of lower leg

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06138977
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT06138977 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Michigan and is currently Recruiting. The study focuses on Amputation. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.